Research graph
References from Protocol for standardized minimally invasive mouse models of bisphosphonate-related and radiation-induced jaw osteonecrosis. Local targets link to admitted publications; unresolved targets remain external evidence.
Drug efficacy and safety of denosumab, teriparatide, zoledronic acid, and ibandronic acid for the treatment of postmenopausal osteoporosis: a network meta-analysis of randomized controlled trials
2023 · External reference
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease
10.1038/s41408-024-01046-2 · 2024 · External reference
Multidisciplinary approach for medication-related osteonecrosis of the jaws: a case report and literature review
10.7181/acfs.2024.0091 · 2025 · External reference
Frequency of osteonecrosis in bisphosphonate users submitted to dental procedures: A systematic review
10.1111/odi.14003 · 2023 · External reference
Review of Osteoradionecrosis of the Jaw: Radiotherapy Modality, Technique, and Dose as Risk Factors
10.3390/jcm12083025 · 2023 · External reference
Bisphosphonate-Related Osteonecrosis of the Jaw and Oral Microbiome: Clinical Risk Factors, Pathophysiology and Treatment Options
10.3390/ijms25158053 · 2024 · External reference
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
10.1002/ijc.35278 · 2025 · External reference
Longitudinal evaluation of health-related quality of life after osteoradionecrosis of the mandible
10.1016/j.bjoms.2015.07.008 · 2015 · External reference
The incidence of osteoradionecrosis of the jaws in oral cavity cancer patients treated with intensity-modulated radiotherapy: a systematic review and meta-analysis
10.1016/j.oooo.2024.04.008 · 2024 · External reference
Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper
10.14219/jada.archive.2005.0108 · 2005 · External reference
Dose translation from animal to human studies revisited
10.1096/fj.07-9574lsf · 2008 · External reference
Bisphosphonate actions: physical chemistry revisited
10.1016/j.bone.2006.01.141 · 2006 · External reference
Preclinical models of medication-related osteonecrosis of the jaw (MRONJ)
2021 · External reference
The effects of Zoledronate administration routes on the reproducibility of BRONJ in rodent models: A systematic review
10.1016/j.bone.2025.117563 · 2025 · External reference
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
10.1038/nature13145 · 2014 · External reference
Lymphatic vessels in bone support regeneration after injury
10.1016/j.cell.2022.12.031 · 2023 · External reference
PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis
10.1038/nm.3668 · 2014 · External reference
Chronic Periodontal Infection and Not Iatrogenic Interference Is the Trigger of Medication-Related Osteonecrosis of the Jaw: Insights from a Large Animal Study (PerioBRONJ Pig Model)
2023 · External reference
American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update
10.1016/j.joms.2022.02.008 · 2022 · External reference
ONJ (MRONJ) Update 2024: Osteonecrosis of the Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment—A National Italian Symposium
10.3390/oral5020025 · 2025 · External reference
Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)
10.1038/s41368-022-00182-4 · 2022 · External reference
An evidence-guided review of preclinical strategies to counteract medication-related osteonecrosis of the jaw. What do rodent studies tell us?
10.1093/jbmrpl/ziaf182 · 2026 · External reference
